コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 thesis of ligands that inhibit the DAF-12, a nuclear hormone receptor.
2 oform a, suggesting an anabolic role for the nuclear hormone receptor.
3 s transcription by thyroid hormone and other nuclear hormone receptors.
4 e largely been credited to the activation of nuclear hormone receptors.
5 actor Nur77 belongs to the NR4A subfamily of nuclear hormone receptors.
6 juba as a unique corepressor for a subset of nuclear hormone receptors.
7 esylation, can act as an agonist for several nuclear hormone receptors.
8 aracteristic of coactivators/corepressors of nuclear hormone receptors.
9 ax lethal toxin (LeTx) selectively represses nuclear hormone receptors.
10 tional repression complexes recruited by the nuclear hormone receptors.
11 ation by SHP is dependent on the presence of nuclear hormone receptors.
12 with inactivation of repression mediated by nuclear hormone receptors.
13 gand-dependent transcriptional activation by nuclear hormone receptors.
14 t suggests a new paradigm for this family of nuclear hormone receptors.
15 ds to and influences the activity of several nuclear hormone receptors.
16 se in O-GlcNAc levels inhibits activation of nuclear hormone receptors.
17 re members of the family of ligand-dependent nuclear hormone receptors.
18 g delivery to tumor cells with overexpressed nuclear hormone receptors.
19 also shed light on the natural evolution of nuclear hormone receptors.
20 LBPs is to deliver small-molecule ligands to nuclear hormone receptors.
21 the clinical efficacy of agents that target nuclear hormone receptors.
22 led an evolutionarily conserved template for nuclear hormone receptors.
23 homeostatic processes that are controlled by nuclear hormone receptors.
24 Pase 12 (vha-12) and its upstream regulator, nuclear hormone receptor 31 (nhr-31), abolished the resc
25 ceptors (RXRs) are important transcriptional nuclear hormone receptors, acting as either homodimers o
29 breast cancer cells with probe 4 attenuates nuclear hormone receptor activity mediated by retinoic a
30 ponent of the Mediator complex that controls nuclear hormone receptor activity, are repressed by miR-
31 he diversification of binding motifs for the nuclear hormone receptor and C2H2 zinc finger families a
32 rkers of the basal-like phenotype, including nuclear hormone receptor and HER2 negativity, cytokerati
35 r gamma (PPARgamma) belongs to the family of nuclear hormone receptors and consists of two isotypes,
36 d prevents these fatty acids from activating nuclear hormone receptors and driving fat-7 expression.
37 ted the binding of 75 TFs, including several nuclear hormone receptors and ETS factors, to the highly
38 s (PPARs) (alpha, gamma, and delta/beta) are nuclear hormone receptors and ligand-activated transcrip
39 ctivator is a property shared with mammalian nuclear hormone receptors and likely allows greater tran
40 st metabolic genes via its interactions with nuclear hormone receptors and nuclear respiratory factor
41 Mediator (MED) facilitates transcription of nuclear hormone receptors and other transcription factor
42 r (NRC) is a 2,063-amino-acid coregulator of nuclear hormone receptors and other transcription factor
43 ochondrial biogenesis through stimulation of nuclear hormone receptors and other transcription factor
44 of TRAP/Mediator that targets the complex to nuclear hormone receptors and other types of activators.
45 of 0.7 nM with great selectivity over other nuclear hormone receptors and potently activated AR in a
46 we show that the direct interaction between nuclear hormone receptors and Prox1 is also necessary fo
47 s that logically explain the coordination of nuclear hormone receptors and the clock are poorly under
48 role of mammalian hADA3 as a coactivator of nuclear hormone receptors and the potential role of thes
49 nalysis will stimulate further research into nuclear hormone receptors and their associated transcrip
50 region in the ZnF_C4 signature motif of the nuclear hormone receptors and thus against the entire re
51 ative lipophilic hormone receptors, known as nuclear hormone receptors, and analyzed their functions
52 of drug targets (receptor tyrosine kinases, nuclear hormone receptors, and cytoplasmic protein kinas
53 mplex relationships among the immune system, nuclear hormone receptors, and inflammation during regre
54 uch an analysis has been carried out for the nuclear hormone receptors, and the conclusions tested by
56 ligand-regulated transcription factors, the nuclear hormone receptors are nearly ideal drug targets,
57 ole in mediating the effects of ligand-bound nuclear hormone receptors as well as other transcription
58 ies of transcriptional regulators, including nuclear hormone receptors, basic helix-loop-helix, ETS-
59 arly perfect direct repeats of the consensus nuclear hormone receptor binding element AGGTCA separate
60 PGC-1alpha differ in their interactions with nuclear hormone receptors but are highly similar in thei
62 transcriptional efficacy of ligand activated nuclear hormone receptors by up to 8-fold in vitro and i
63 17 cell markers retinoic acid-related orphan nuclear hormone receptor c (RORc), IL-17A, and IL-23R.
64 pression of the retinoic acid-related orphan nuclear hormone receptor C and IL-17A and secretion of I
65 e inhibition of retinoic acid-related orphan nuclear hormone receptor C and IL-17A gene expression an
66 e expression of retinoic acid-related orphan nuclear hormone receptor C, a transcription factor that
67 g, in part through the local availability of nuclear hormone receptors called retinoic acid receptors
69 usly been demonstrated to associate with the nuclear hormone receptor coactivator AIB1/SRC-3, the que
71 3 (SRC-3) is a histone acetyltransferase and nuclear hormone receptor coactivator, located on 20q12,
74 ic Ecdysone receptor/Ultraspiracle (ECR/USP) nuclear hormone receptor complex throughout the entire n
75 significantly, the footprint sequences bind nuclear hormone receptor complexes in male, but not fema
76 ata are consistent with the possibility that nuclear hormone receptor complexes participate in the es
82 the FOXO transcription factor DAF-16 and the nuclear hormone receptor DAF-12 and influences metabolic
84 l timing and longevity through the conserved nuclear hormone receptor DAF-12, a homolog of mammalian
85 lifespan of C. elegans are controlled by the nuclear hormone receptor DAF-12, an important model for
89 developmental trajectories interact with the nuclear hormone receptor, DAF-12, to initiate and regula
92 cadian and major hormonal circuits involving nuclear hormone receptors display interlinked diurnal cy
94 XA7 promoter identified a cluster of steroid nuclear hormone receptor elements, including V$GREF (V$G
95 lk" between a membrane receptor (CD44) and a nuclear hormone receptor (ER alpha) signaling pathway du
96 nhr-23 and nhr-25, genes encoding conserved nuclear hormone receptors essential for larval molting.
100 interact with the androgen receptor (AR), a nuclear hormone receptor expressed at high levels in Ser
101 ted basal-like differentiation and repressed nuclear hormone receptor expression after short-term PTE
102 d entry mechanism for members of the steroid nuclear hormone receptor family (androgen receptor, estr
103 oic acid receptors (RARs) are members of the nuclear hormone receptor family and regulate the prolife
104 d receptors (PPARs) and other members of the nuclear hormone receptor family are important drug targe
105 he androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors
106 he androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors
107 ERBalpha (encoded by Nr1d1), a member of the nuclear hormone receptor family, as a transcriptional re
108 receptor-gamma (PPARgamma), a member of the nuclear hormone receptor family, is a master regulator o
109 tivated receptors (PPARs) are members of the nuclear hormone receptor family, playing pivotal roles i
110 farnesoid X receptor (FXR), a member of the nuclear hormone receptor family, plays important roles i
111 receptor gamma (PPARgamma), a member of the nuclear hormone receptor family, represents a possible n
112 n bisphenols and ERs or other members of the nuclear hormone receptor family, such as estrogen-relate
113 rogen receptor alpha (ER) is a member of the nuclear hormone receptor family, which upon binding estr
115 r prior studies with the bile acid-activated nuclear hormone receptor farnesoid X receptor (FXR) and
119 ated three dominant, X-linked mutants in the nuclear hormone receptor gene nhr-40 that are haploinsuf
120 nzalutamide via activation of an alternative nuclear hormone receptor, glucocorticoid receptor (GR),
121 ember of the p160 family of coactivators for nuclear hormone receptors, has been frequently detected
123 dermal ontogenesis is poorly understood, but nuclear hormone receptors have been shown to have an imp
126 five footprinted areas contains at least two nuclear hormone receptor hexad binding sites arranged wi
127 d oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respecti
128 expressed from lentiviruses and (3) that the nuclear hormone receptor HNF4A is essential for specific
129 We find that the SF1-related Drosophila nuclear hormone receptor HR39 is also essential for sexu
131 down expression after adult eclosion of the nuclear hormone receptor Hr39, a master regulator of gla
132 ell-described cotranscriptional activator of nuclear hormone receptors (i.e., Sp1), the hypothesis th
133 previously unrecognized role for this orphan nuclear hormone receptor in regulating STAT1 signaling a
134 s requires understanding the pivotal role of nuclear hormone receptors in lipid and inflammatory home
135 o explore the roles of dynamically expressed nuclear hormone receptors in molting, and to analyze mei
138 uggest a potential role for dysregulation of nuclear hormone receptors in the pathogenesis of ADPKD.
139 tion studies, and elucidation of the role of nuclear hormone receptors in the regulation of bile salt
140 amined the expression patterns of a panel of nuclear hormone receptors in these two cell lines and de
142 (also known as GPBAR1, M-BAR, and BG37) and nuclear hormone receptors including farnesoid X receptor
144 ember of the p160 family of coactivators for nuclear hormone receptors including the androgen recepto
145 ow-density lipoprotein receptor (LOX-1); the nuclear hormone receptors, including peroxisome-prolifer
146 are not available to cell surface receptors, nuclear hormone receptors, ion channels, transporters, a
148 dogenic factor SF-1, a constitutively active nuclear hormone receptor, is essential to the developmen
149 factor 4alpha (HNF4alpha), a liver-enriched nuclear hormone receptor, is markedly inhibited, whereas
150 though NIF-1 does not directly interact with nuclear hormone receptors, it enhances activation by nuc
151 binding site in the AKR1C4 promoter for the nuclear hormone receptor known as liver X receptor alpha
152 Small heterodimer partner (SHP), an orphan nuclear hormone receptor lacking a DNA binding domain, i
157 r of metabolism and inflammation, the orphan nuclear hormone receptor, liver receptor homolog-1 (LRH-
158 nd genetic evidence establishing the liver-X nuclear hormone receptor (LXR) as a therapeutic target i
159 thesis in HepG2 cells suggests that multiple nuclear hormone receptors mediate viral replication in t
161 the development of BPA substitutes devoid of nuclear hormone receptor-mediated activity and more gene
162 raction identifies a site of convergence for nuclear hormone receptor-mediated and VSMC-specific gene
163 s Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene activation and ma
164 eptor lacking a DNA binding domain, inhibits nuclear hormone receptor-mediated viral transcription an
165 soid X receptor (FXR), a bile acid-activated nuclear hormone receptor, modulates renal SREBP-1 expres
171 thway, the abnormal DAuer Formation (DAF) 12 nuclear hormone receptor (NHR) pathway, functions cell-i
172 lapping feedback loops that are modulated by nuclear hormone receptors (NHR), miRNAs, and epigenetic
173 er in controlling gene regulation in nature, nuclear hormone receptors (NHRs) have largely eluded uti
178 d hormone receptors (TRs) are members of the nuclear hormone receptor (NR) superfamily and regulate d
187 Synthetic peptides that specifically bind nuclear hormone receptors offer an alternative approach
189 vestigated the possibility that the GATA and nuclear hormone receptor pathways are functionally linke
198 tion (mediated by CDK9), and activity of the nuclear hormone receptor peroxisome proliferator-activat
199 responses, we examined the expression of the nuclear hormone receptor peroxisome proliferator-activat
200 nosa (PAO1) is enhanced by activation of the nuclear hormone receptor peroxisome proliferator-activat
202 -inflammatory actions both by activating the nuclear hormone receptor peroxisome proliferator-activat
203 ized low-density lipoprotein receptor-1, the nuclear hormone receptors peroxisome proliferator-activa
204 of CML through their ability to activate the nuclear hormone receptor, peroxisome proliferator activa
206 thyl ascochlorin (AS-6) is an agonist of the nuclear hormone receptor PPARgamma and has been shown to
207 pase D2 (PLD2) and binds to and inhibits the nuclear hormone receptor PPARgamma with nanomolar affini
210 hormone receptors, it enhances activation by nuclear hormone receptors presumably through its interac
211 iferator-activated receptor (PPAR)gamma is a nuclear hormone receptor primarily characterized for its
216 The difficulty in identifying ligands for nuclear hormone receptors remains an obstacle to underst
218 dden Markov model for predictive modeling of nuclear hormone receptor response elements coupled with
219 ediate transcriptional activation by RA, the nuclear hormone receptor retinoic acid receptor (RAR) an
220 of the transcriptional repressor Id2 and the nuclear hormone receptor retinoic acid-related orphan re
222 LG100268 (LG268), a synthetic ligand for the nuclear hormone receptor retinoid X receptor, on the exp
225 ptional activation cell assays and in silico nuclear hormone receptor screening revealed that certain
226 ents for a series of target families: GPCRs, nuclear hormone receptors, serine proteases, protein kin
228 on factor Wt1 to stimulate expression of the nuclear hormone receptor Sf-1 (Nr5a1) in the AGP prior t
230 ction cascades (PI3K and MAPK) converging on nuclear hormone receptors (SF-1/LRH-1) to modulate their
231 , we report that an evolutionarily conserved nuclear hormone receptor signaling pathway governs devel
232 ated intersection between these two critical nuclear hormone receptor signaling pathways provides a g
233 ide G-protein-coupled receptors (GPCRs), and nuclear hormone receptors significantly exceed limits fo
237 ortant mediators of CYP3A4 expression is the nuclear hormone receptor, steroid and xenobiotic recepto
239 hree members of the NR4A1/Nur77/NGFIB orphan nuclear hormone receptor subfamily (NR4A1, NR4A2, and NR
240 r coactivator-1 (SRC-1) is a coactivator for nuclear hormone receptors such as estrogen and progester
241 has been shown to act as a co-activator for nuclear hormone receptors such as estrogen receptor (ER)
243 seven-transmembrane G-coupled receptors, and nuclear hormone receptors, suggesting that they provide
247 ted receptor (PPAR)-gamma is a member of the nuclear hormone receptor superfamily that can promote ce
248 farnesoid X receptor (FXR), a member of the nuclear hormone receptor superfamily, and TGR5, a G prot
250 the liver X receptor (LXR), a member of the nuclear hormone receptor superfamily, inhibits inflammat
251 r the Liver X Receptor (LXR), members of the nuclear hormone receptor superfamily, prevent the develo
252 or alpha (PPARalpha) is a member of the PPAR nuclear hormone receptor superfamily, which can be activ
253 d X receptor (FXR, NR1H4) is a member of the nuclear hormone receptor superfamily, which plays an ess
265 receptor homolog 1 (LRH-1; NR5A2), an orphan nuclear hormone receptor that controls lipid and glucose
266 Estrogen receptor alpha (ER-alpha) is a nuclear hormone receptor that controls selected genes, t
268 ator-activated receptor gamma (PPARgamma), a nuclear hormone receptor that exhibits wound-healing and
269 or-activated receptor-gamma (PPARgamma) is a nuclear hormone receptor that is critical for adipogenes
270 is elegans, uncoordinated (unc)-55 encodes a nuclear hormone receptor that is necessary for coordinat
271 -regulated genes, including Nr4a1, an orphan nuclear hormone receptor that negatively regulates NF-ka
272 soid X receptor (FXR), a bile acid-activated nuclear hormone receptor that regulates bile acid metabo
274 ceptor homolog 1 (NR5A2, LRH-1) is an orphan nuclear hormone receptor that regulates diverse biologic
275 nist of the farnesoid X receptor, which is a nuclear hormone receptor that regulates glucose and lipi
276 ptor (PXR) and formally known as NR1I2] is a nuclear hormone receptor that regulates inducible metabo
277 patterning requires thyroid hormone beta2, a nuclear hormone receptor that regulates transcription in
279 proliferator-activated receptors (PPARs) are nuclear hormone receptors that act as ligand-activated t
280 tivated receptors (PPARs) are a subfamily of nuclear hormone receptors that function as ligand-activa
281 d gamma (RARalpha, RARbeta and RARgamma) are nuclear hormone receptors that regulate fundamental proc
282 NCOA4 is a transcriptional coactivator of nuclear hormone receptors that undergoes gene rearrangem
284 e following pregnancy lack the expression of nuclear hormone receptors, thereby recapitulating many c
285 e ability to interact with and transactivate nuclear hormone receptors through its N-terminal transac
287 primarily through cognate sterol-responsive nuclear hormone receptors to control these processes thr
289 motor neurons and, together with the UNC-55 nuclear hormone receptor, to prevent aberrant VD synapti
290 alpha/PPARalpha, plus potentially additional nuclear hormone receptors, to HBV RNA synthesis and repl
291 g the well-established role of the conserved nuclear hormone receptor transcription factor, NHR-23/NR
292 rotein classes (G protein-coupled receptors, nuclear hormone receptors, voltage- and ligand-gated ion
293 nism of ligand dependence is not specific to nuclear hormone receptors, we anticipate that our protei
294 erythroid-derived 2, heat shock factor, and nuclear hormone receptors, which regulate stress-respons
295 ator-activated receptor gamma (PPARgamma), a nuclear hormone receptor with anti-inflammatory effects,
296 ivation of the liver X receptor, LXRalpha, a nuclear hormone receptor with known roles in hepatic lip
297 lting through the ecdysone receptor (EcR), a nuclear hormone receptor with numerous targets including
298 which combine the ligand-binding domains of nuclear hormone receptors with a highly sensitive thymid
299 This approach has been recently expanded to nuclear hormone receptors with the introduction of "phot
300 fold selectivity versus PR and other related nuclear hormone receptors, with improved solubility as c